| Bioactivity | FITC-Ahx Gly Arg Gly Asp Ser Pro is a GRGDSP (HY-P0290) coupled to FITC. GRGDSP is an integrin inhibitor that can inhibit the adherence of tumor cells to endothelial cells of blood vessels and limit its metastasis[1]. |
| Name | FITC-Ahx-Gly-Arg-Gly-Asp-Ser-Pro |
| CAS | 2022956-44-9 |
| Sequence | {FITC-εAhx}-Gly-Arg-Gly-Asp-Ser-Pro |
| Shortening | {FITC-εAhx}-GRGDSP |
| Formula | C49H59N11O16S |
| Molar Mass | 1090.12 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Qian J, et al. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model. World J Gastroenterol. 2016 Jun 7;22(21):5042-9. |
FITC-Ahx-Gly-Arg-Gly-Asp-Ser-Pro
CAS: 2022956-44-9 F: C49H59N11O16S W: 1090.12
FITC-Ahx Gly Arg Gly Asp Ser Pro is a GRGDSP (HY-P0290) coupled to FITC. GRGDSP is an integrin inhibitor that can inhibi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.